Saturday, 1 February 2020




Session I: Overview and Epidemiology of Adult and Pediatric Cancer Diseases: “Experiences Gained and Lessons Learned” Moderators: Dr. Reyad Mohsen, Dr. Abeer Alsayegh, Dr. Noora Alhammadi


Registration & Breakfast



Landscape of cancer genetic in Qatar current and future prospective

Dr. Salha Bujassoum Al Bader
Sr consultant medical oncologist / clinical leads of high risk - cancer genetic program / director of medical oncology fellowship training. Hamad Medical Corporation Qatar


Overview on pediatric rare cancers: experience from Qatar

Dr. Naima Almulla
Sr Consultant, Pediatric Hematology and Oncology, Sidra Medicine


Identification and characterization of rare pediatric brain tumor entities

Dr. David Jones
Group Leader - Pediatric Glioma Research, Hopp Children’s Cancer Center Heidelberg (KiTZ)


Rare cancer predisposition syndromes in children and adults

Dr. Nicola Dikow
Consultant, Institute of Human Genetics University of Heidelberg


Short coffee break followed by

Welcome and Opening Remarks from Dr. Saad Al Kaabi

Keynote Lecture: German Center for Rare Diseases
(Prof. Annette Grueters-Kieslich)

Dr. Saad Al Kaabi
Conference Chairperson

Prof. Annette Grueters-Kieslich

Session II

Prevention and Ethical Considerations in Genomic Medicine

Moderators: Dr. Tawfeg Ben Omran, Karen El-Akouri


Ethical and cultural considerations in genomic medicine

Dr. Al Hareth Al Khater
Deputy Medical Director, National Center for Cancer Care & Research, Chairman, Corporate Healthcare Ethics Committee, Hamad Medical Corporation


Islamic ethics in the genomic era

Dr. Mohamed Ghaly
Professor of Islam and Biomedical Ethics Research Center for Islamic Legislation & Ethics (CILE), College of Islamic Studies (CIS), Hamad Bin Khalifa University (HBKU)


Premarital genetic screening and counseling in Qatar

Dr. Mariam Al Mulla
Genetic Counselor, Department of Pediatrics, Hamad Medical Corporation


Prevention programs for hereditary cancer in Qatar

Dr. Reem Al Sulaiman
Interim Deputy Chair Medical Genetics Department, HMC
Assistant Chair of Rare Disease and Research Committee, HMC


Prayer & Lunch Break


Session III

Therapeutic Opportunities in the Era of Genomic Medicine: “Challenges and Success”

Moderators: Dr. Khaled Zamel, Dr. Javid Gaziev, Dr. Amna Gamil


An emerging treatment option for spinal muscular atrophy: “from lethality to cure”

Dr. Tawfeg Ben-Omran
MD Clinical and Metabolic Genetic Hamad Medical Corporation and Sidra Medicine Associate Professor, Weill Cornell Medical College


Gene therapy for hemoglobinopathies

Prof. Andreas Kulozik
Medical Director, Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg


Anemia of inflammation & iron in macrophages

Prof. Martina Muckenthaler
Department of Pediatric Oncology, Hematology, Immunology & Pulmonology, University of Heidelberg


Therapeutic advances in neurotransmitter disorders

Prof. Thomas Opladen
Deputy Head, Pediatric Neurology and Metabolic Medicine University of Heidelberg


Towards precision medicine in skin diseases

Prof. Martin Steinhoff
Chairman, Dept. of Dermatology & Venereology Director, HMC Translational Research Institute (iTRI) Director, HMC Institute for Dermatology Center of Excellence Chronic Skin Inflammation

Session IV

Living with Rare Diseases: Parents’ Experiences

Moderators: Dr. Tawfeg Ben Omran, Dr. Reem Alsulaiman


Parent 1 & 2


Closing of Day 1